Three-strain probiotic modestly eases menopausal symptoms in real-world trial

This randomized trial adds preliminary controlled evidence that a specific three-strain probiotic formula produces a small but statistically significant reduction in menopausal symptom burden, offering Women's Health pharmacists a nonhormone data point to contextualize for patients seeking supplement-based options.

probioticsLevilactobacillus brevisLactiplantibacillus plantarumPediococcus acidilacticimenopauseperimenopausepostmenopausenonhormone therapyquality of lifeMenopause Rating Scalerandomized controlled trialwomen's health Women's Health

Background Information

Probiotics may ease menopause symptoms and improve quality of life.

Menopausal symptoms significantly affect quality of life, and current treatments have limitations. Exploring alternatives like probiotics could offer new options. The probiotic group showed significant improvement in the Menopause Rating Scale II total score compared to placebo, particularly in somato-vegetative symptoms and overall quality of life. While promising, the effect was modest and further studies are needed to confirm the clinical significance of these findings. Probiotics may improve some menopausal symptoms and quality of life, with further research needed.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Rodríguez-Palmero M, Prat C, Molina X, Miras F, Huedo P, Perez M, Espadaler-Mazo J, Palacios S, González SP

Citation: Rodríguez-Palmero M, Prat C, Molina X, et al. Efficacy of a probiotic formula in the management of menopausal symptoms and quality of life: a randomized controlled trial. Menopause (New York, N.Y.). 2026. doi:10.1097/GME.0000000000002871

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →